Search research articles
Contact Us
Filters
Showing results (111-120 of 149) with videos related to
Page
of 15
Sort By:
The Journal of Urology
|
June 28, 2021
Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical Cystectomy
Victor M Schuettfort, Benjamin Pradere, David D'Andrea, et al.
The Prostate
|
May 31, 2021
The role of lymph node dissection in salvage radical prostatectomy for patients with radiation recurrent prostate cancer
Fahad Quhal, Pawel Rajwa, Keiichiro Mori, et al.
Urologic Oncology
|
June 12, 2021
Impact of systemic Immune-inflammation Index on oncologic outcomes in patients treated with radical prostatectomy for clinically nonmetastatic prostate cancer
Pawel Rajwa, Victor M Schuettfort, David D'Andrea, et al.
Cancer Immunology, Immunotherapy : CII
|
February 25, 2026
A real-world comparison of nivolumab plus cabozantinib and pembrolizumab plus lenvatinib focusing on safety outcomes in metastatic renal cell carcinoma: results from the JK-FOOT consortium
Takafumi Yanagisawa, Keiichiro Mori, Tatsushi Kawada, et al.
Minerva Urology and Nephrology
|
July 26, 2021
Androgen receptor axis-targeted agents for non-metastatic castration-resistant prostate cancer impact on overall survival and safety profile
Keiichiro Mori, Fahad Quhal, Satoshi Katayama, et al.
Clinical Genitourinary Cancer
|
February 7, 2022
Neoadjuvant Chemotherapy in Elderly Patients With Upper Tract Urothelial Cancer: Oncologic Outcomes From a Multicenter Study
Nico C Grossmann, Benjamin Pradere, David D'Andrea, et al.
Japanese Journal of Clinical Oncology
|
August 23, 2024
Clinical outcomes and prognostic factors in metastatic nonclear cell renal cell carcinoma treated with immuno-oncology combination therapy
Shingo Toyoda, Wataru Fukuokaya, Keiichiro Mori, et al.
International Journal of Clinical Oncology
|
September 5, 2025
Predictors of early progressive disease and antitumor effects by metastatic site in renal cell carcinoma treated with ipilimumab plus nivolumab
Keiichiro Mori, Takafumi Yanagisawa, Tatsushi Kawada, et al.
Clinical Genitourinary Cancer
|
November 12, 2021
Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma
Keiichiro Mori, Satoshi Katayama, Ekaterina Laukhtina, et al.
Clinical Genitourinary Cancer
|
May 19, 2024
Effect of Antacids on the Survival of Patients With Metastatic Urothelial Carcinoma Treated With Pembrolizumab
Takanori Sekito, Kensuke Bekku, Satoshi Katayama, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 149) with videos related to
Sort By:
Page
of 15
The Journal of Urology
|
June 28, 2021
Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical Cystectomy
Victor M Schuettfort, Benjamin Pradere, David D'Andrea, et al.
The Prostate
|
May 31, 2021
The role of lymph node dissection in salvage radical prostatectomy for patients with radiation recurrent prostate cancer
Fahad Quhal, Pawel Rajwa, Keiichiro Mori, et al.
Urologic Oncology
|
June 12, 2021
Impact of systemic Immune-inflammation Index on oncologic outcomes in patients treated with radical prostatectomy for clinically nonmetastatic prostate cancer
Pawel Rajwa, Victor M Schuettfort, David D'Andrea, et al.
Cancer Immunology, Immunotherapy : CII
|
February 25, 2026
A real-world comparison of nivolumab plus cabozantinib and pembrolizumab plus lenvatinib focusing on safety outcomes in metastatic renal cell carcinoma: results from the JK-FOOT consortium
Takafumi Yanagisawa, Keiichiro Mori, Tatsushi Kawada, et al.
Minerva Urology and Nephrology
|
July 26, 2021
Androgen receptor axis-targeted agents for non-metastatic castration-resistant prostate cancer impact on overall survival and safety profile
Keiichiro Mori, Fahad Quhal, Satoshi Katayama, et al.
Clinical Genitourinary Cancer
|
February 7, 2022
Neoadjuvant Chemotherapy in Elderly Patients With Upper Tract Urothelial Cancer: Oncologic Outcomes From a Multicenter Study
Nico C Grossmann, Benjamin Pradere, David D'Andrea, et al.
Japanese Journal of Clinical Oncology
|
August 23, 2024
Clinical outcomes and prognostic factors in metastatic nonclear cell renal cell carcinoma treated with immuno-oncology combination therapy
Shingo Toyoda, Wataru Fukuokaya, Keiichiro Mori, et al.
International Journal of Clinical Oncology
|
September 5, 2025
Predictors of early progressive disease and antitumor effects by metastatic site in renal cell carcinoma treated with ipilimumab plus nivolumab
Keiichiro Mori, Takafumi Yanagisawa, Tatsushi Kawada, et al.
Clinical Genitourinary Cancer
|
November 12, 2021
Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma
Keiichiro Mori, Satoshi Katayama, Ekaterina Laukhtina, et al.
Clinical Genitourinary Cancer
|
May 19, 2024
Effect of Antacids on the Survival of Patients With Metastatic Urothelial Carcinoma Treated With Pembrolizumab
Takanori Sekito, Kensuke Bekku, Satoshi Katayama, et al.
Page
of 15